Illumina Inc. (ILMN): Price and Financial Metrics
ILMN Price/Volume Stats
Current price | $143.33 | 52-week high | $238.55 |
Prev. close | $142.94 | 52-week low | $89.00 |
Day low | $139.19 | Volume | 2,435,400 |
Day high | $144.85 | Avg. volume | 1,885,648 |
50-day MA | $132.34 | Dividend yield | N/A |
200-day MA | $156.74 | Market Cap | 22.76B |
ILMN Stock Price Chart Interactive Chart >
ILMN POWR Grades
- Quality is the dimension where ILMN ranks best; there it ranks ahead of 77.78% of US stocks.
- ILMN's strongest trending metric is Quality; it's been moving up over the last 26 weeks.
- ILMN ranks lowest in Momentum; there it ranks in the 27th percentile.
ILMN Stock Summary
- ILMN has a higher market value than 89.55% of US stocks; more precisely, its current market capitalization is $20,697,992,000.
- Price to trailing twelve month operating cash flow for ILMN is currently 51.62, higher than 93.38% of US stocks with positive operating cash flow.
- In terms of twelve month growth in earnings before interest and taxes, ILLUMINA INC is reporting a growth rate of -74.09%; that's higher than merely 18% of US stocks.
- If you're looking for stocks that are quantitatively similar to ILLUMINA INC, a group of peers worth examining would be CYCN, MRCY, QLGN, SMSI, and BHIL.
- Visit ILMN's SEC page to see the company's official filings. To visit the company's web site, go to www.illumina.com.
ILMN Valuation Summary
- ILMN's price/earnings ratio is -19.7; this is 167.58% lower than that of the median Healthcare stock.
- Over the past 243 months, ILMN's price/earnings ratio has gone down 11.2.
Below are key valuation metrics over time for ILMN.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
ILMN | 2023-12-29 | 5.0 | 3.7 | -19.7 | -22.3 |
ILMN | 2023-12-28 | 5.1 | 3.8 | -20.1 | -22.7 |
ILMN | 2023-12-27 | 5.1 | 3.8 | -20.1 | -22.8 |
ILMN | 2023-12-26 | 5.0 | 3.8 | -19.9 | -22.5 |
ILMN | 2023-12-22 | 5.0 | 3.8 | -19.8 | -22.4 |
ILMN | 2023-12-21 | 5.0 | 3.8 | -19.8 | -22.4 |
ILMN Growth Metrics
- Its year over year net cashflow from operations growth rate is now at -59.76%.
- Its 4 year revenue growth rate is now at 46.66%.
- The year over year cash and equivalents growth rate now stands at -69.52%.
The table below shows ILMN's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 4,584 | 392 | -4,404 |
2022-09-30 | 4,699 | 527 | -4,153 |
2022-06-30 | 4,692 | 307 | -20 |
2022-03-31 | 4,656 | 435 | 700 |
2021-12-31 | 4,526 | 545 | 762 |
2021-09-30 | 4,280 | 669 | 906 |
ILMN's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ILMN has a Quality Grade of B, ranking ahead of 94.64% of graded US stocks.
- ILMN's asset turnover comes in at 0.489 -- ranking 48th of 75 Measuring and Control Equipment stocks.
- AMOT, AATC, and TRMB are the stocks whose asset turnover ratios are most correlated with ILMN.
The table below shows ILMN's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-07-04 | 0.489 | 0.686 | 0.187 |
2021-04-04 | 0.448 | 0.676 | 0.175 |
2021-01-03 | 0.439 | 0.680 | 0.173 |
2020-09-27 | 0.443 | 0.690 | 0.165 |
2020-06-28 | 0.464 | 0.703 | 0.174 |
2020-03-29 | 0.497 | 0.704 | 0.209 |
ILMN Price Target
For more insight on analysts targets of ILMN, see our ILMN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $459.00 | Average Broker Recommendation | 1.92 (Hold) |
Illumina Inc. (ILMN) Company Bio
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California. (Source:Wikipedia)
Latest ILMN News From Around the Web
Below are the latest news stories about ILLUMINA INC that investors may wish to consider to help them evaluate ILMN as an investment opportunity.
Here's Why You Should Retain Illumina (ILMN) Stock for NowInvestors are optimistic about Illumina's (ILMN) strength in the genomics market and strong solvency position. |
Small Caps Are On A Tear Including Speculative BiotechsSo far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation. |
Nucleus Genomics Wants To Make Personalized Health Care a RealityNORTHAMPTON, MA / ACCESSWIRE / December 21, 2023 / Illumina A New York-based startup is on a mission to bring the power of whole-genome sequencing to the world Originally published on Illumina News Center Nucleus Genomics is realizing the dream set ... |
Heard on the Street: Illumina Nears the End of Its Painful Grail SagaGrail’s screening test, called Galleri, could one day help save countless lives by catching cancer in the bloodstream early. After losing in court [against the Federal Trade Commission](https://www.wsj.com/health/healthcare/court-sides-with-ftc-finding-illumina-grail-deal-anticompetitive-ad2efe8d), the company has finally [thrown in the towel](https://www.wsj.com/health/healthcare/illumina-to-divest-itself-of-cancer-test-maker-grail-3f74f1e8) on keeping Grail. The maker of gene-sequencing machines said Sunday it will pursue the divestiture of Grail through a third-party sale or capital markets transaction, with a goal of completing terms by the middle of 2024. |
S&P 500 Gains and Losses Today: Enphase's Cost Cutting Charges Up Solar StocksThe S&P 500 gained 0.6% on Tuesday, Dec. 19, 2023, amid optimism on Fed rate cuts, strong housing data, and the traditional "Santa Claus rally." |
ILMN Price Returns
1-mo | 2.57% |
3-mo | 45.70% |
6-mo | -20.58% |
1-year | -27.79% |
3-year | -68.22% |
5-year | -49.55% |
YTD | 2.94% |
2023 | -31.14% |
2022 | -46.85% |
2021 | 2.82% |
2020 | 11.53% |
2019 | 10.61% |
Continue Researching ILMN
Want to do more research on Illumina Inc's stock and its price? Try the links below:Illumina Inc (ILMN) Stock Price | Nasdaq
Illumina Inc (ILMN) Stock Quote, History and News - Yahoo Finance
Illumina Inc (ILMN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...